Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Long-Term Deferred Tax (2019 - 2025)

Phibro Animal Health (PAHC) has 7 years of Long-Term Deferred Tax data on record, last reported at $23.5 million in Q3 2025.

  • For Q3 2025, Long-Term Deferred Tax fell 7.76% year-over-year to $23.5 million; the TTM value through Sep 2025 reached $23.5 million, down 7.76%, while the annual FY2025 figure was $25.5 million, 31.89% up from the prior year.
  • Long-Term Deferred Tax reached $23.5 million in Q3 2025 per PAHC's latest filing, down from $25.5 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $33.8 million in Q4 2024 and bottomed at $4.1 million in Q1 2022.
  • Average Long-Term Deferred Tax over 5 years is $15.7 million, with a median of $12.2 million recorded in 2021.
  • Peak YoY movement for Long-Term Deferred Tax: tumbled 40.69% in 2022, then soared 184.22% in 2024.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $8.2 million in 2021, then dropped by 28.56% to $5.8 million in 2022, then skyrocketed by 53.55% to $9.0 million in 2023, then surged by 276.29% to $33.8 million in 2024, then tumbled by 30.33% to $23.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Deferred Tax were $23.5 million in Q3 2025, $25.5 million in Q2 2025, and $33.8 million in Q4 2024.